Scientific Reports · 2017 · 19 citations · 44 references
MedicineInfectious DiseasesPharmacologyAntimicrobial PharmacologyDrug DeliveryPulmonary Drug DeliveryAnti-inflammatory PharmacologyAntibacterial PharmacologyCystic FibrosisInhalation Drug DeliveryPulmonary FormulationsSurfactantsAnti-inflammatory ActivityAnti-inflammatory ResponseBactericidal AgentsExogenous Surfactant AdministrationLipid-based Inhalation FormulationsPulmonary Surfactant AdministrationPulmonary Surfactant TherapyRecurrent Respiratory Infections
Cystic fibrosis (CF) is characterized by recurrent airway infections with antibiotic-resistant bacteria and chronic inflammation. Chicken cathelicin-2 (CATH-2) has been shown to exhibit antimicrobial activity against antibiotic-resistant bacteria and to reduce inflammation. In addition, exogenous pulmonary surfactant has been suggested to enhance pulmonary drug delivery. It was hypothesized that CATH-2 when combined with an exogenous surfactant delivery vehicle, bovine lipid extract surfactant (BLES), would exhibit antimicrobial activity against CF-derived bacteria and downregulate inflammation. Twelve strains of CF-pathogens were exposed to BLES+CATH-2 in vitro and killing curves were obtained to determine bactericidal activity. Secondly, heat-killed bacteria were administered in vivo to elicit a pro-inflammatory response with either a co-administration or delayed administration of BLES+CATH-2 to assess the antimicrobial-independent, anti-inflammatory properties of BLES+CATH-2. CATH-2 alone exhibited potent antimicrobial activity against all clinical strains of antibiotic-resistant bacteria, while BLES+CATH-2 demonstrated a reduction, but significant antimicrobial activity against bacterial isolates. Furthermore, BLES+CATH-2 reduced inflammation in vivo when either co-administered with killed bacteria or after delayed administration. The use of a host-defense peptide combined with an exogenous surfactant compound, BLES+CATH-2, is shown to exhibit antimicrobial activity against antibiotic-resistant CF bacterial isolates and reduce inflammation.
44
Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung
Alejandro A. Pezzulo, Xiao Xiao Tang, Mark J. Hoegger et al. · Nature · 2012 · 807 citations · Full text
NET balancing: a problem in inflammatory lung diseases
Olivia Z. Cheng, Nades Palaniyar · Frontiers in Immunology · 2013 · 451 citations · Full text
Life Sciences, Immunology, Pathology +15